Pixium Vision convoque son Assemblée Générale Annuelle le 13 juin 2023
May 10, 2023 13:00 ET
|
Pixium Vision
Pixium Vision convoque son Assemblée Générale Annuelle le 13 juin 2023 Paris, le 10 mai 2023 – 19 h 00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641 - Mnemo: ALPIX), société...
Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures
May 05, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Audited full year 2022 annual financial figures due to be reported by end of May 2023 Basel, Switzerland, May 5, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage...
AMD Reports First Quarter 2023 Financial Results
May 02, 2023 16:15 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced revenue for the first quarter of 2023 of $5.4 billion, gross margin of 44%, operating loss of $145 million, net...
Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report
April 28, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Ad hoc announcement pursuant to Art. 53 LR Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report Basel, Switzerland, 28...
AMD Introduces Ryzen™ Z1 Series Processors, Expanding the "Zen 4" Lineup into Handheld Game Consoles
April 25, 2023 09:00 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) introduced the new Ryzen Z1 Series processors, the ultimate high-performance processor for handheld PC gaming...
AMD to Report Fiscal First Quarter 2023 Financial Results
April 18, 2023 16:05 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal first quarter 2023 financial results on Tuesday, May 2, 2023, after the close of...
ONL Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of First-in-Class Fas-Inhibitor in Patients with Macula-Off Rhegmatogenous Retinal Detachment
April 12, 2023 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., April 12, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
AMD Names Jack Huynh Senior Vice President and General Manager, Computing and Graphics
April 04, 2023 16:34 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced that Jack Huynh has been named senior vice president and general manager of Computing and Graphics following...
Communication faisant suite à l’annonce de l’obtention du statut Breakthrough Device de la FDA pour le Système Prima dans le traitement de la DMLA sèche
April 03, 2023 01:00 ET
|
Pixium Vision
Communication faisant suite à l’annonce de l’obtention du statut Breakthrough Device de la FDA pour le Système Prima dans le traitement de la DMLA sèche Conversion de 160 ORNAN2022 par ESGO...
Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD
April 03, 2023 01:00 ET
|
Pixium Vision
Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD Conversion of 160 ORNAN2022 by ESGO with intention to pursue controlled trading...